BRD2 and prediabetes syndrome: There were other studies which have reported the associations between serum FSH and cardiometabolic risk in post-menopausal women: low level of FSH in post-menopausal women has been suggested as a risk factor or a biomarker for CVD [18] and speculated as a predictive biomarker of glucose metabolism from the fact of its associations with prediabetes and diabetes [15].